Skip to main content
SpringerLink
Log in

Thrombosis on a mechanical mitral valve anticoagulated with dabigatran

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Roudaut R, Serri K, Lafitte S (2009) Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 93:137–142

    Article  Google Scholar 

  2. Foley PW, Sharma R, Kalra PR (2007) Beware of prosthetic valve thrombosis despite therapeutic anticoagulation. Emerg Med J 24:e18

    Article  PubMed  Google Scholar 

  3. Lengyel M (2008) Diagnosis and treatment of left-sided prosthetic valve thrombosis. Expert Rev Cardiovasc Ther 6:85–93

    Article  PubMed  Google Scholar 

  4. Eriksson BI, Dahl OE, Rosencher N et al (2007) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 370:949–956

    Article  CAS  PubMed  Google Scholar 

  5. Schulman S, Kearon C, Kakkar AK et al (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 364:2342–2352

    Article  Google Scholar 

  6. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151

    Article  CAS  PubMed  Google Scholar 

  7. Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992

    Article  CAS  PubMed  Google Scholar 

  8. Redondo S, Martinez MP, Ramajo M, Navarro-Dorado J, Barez A, Tejerina T (2011) Pharmacological basis and clinical evidence of dabigatran therapy. J Hematol Oncol 4:53

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Van de Werf F, Brueckmann M, Connolly SJ, Friedman J, Granger CB et al (2012) A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). Am Heart J 163:931–937

    Article  PubMed  Google Scholar 

  10. US Food and Drug Administration (2012) FDA drug safety communication: Pradaxa (dabigatran etexiliate mesylate) should not be used in patients with mechanical prosthetic heart valves. US Department of Health and Human Services. www.fda.gov/Drugs/DrugSafety/ucm332912.htm. Accessed 10 April 2013

  11. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, EM PL, Warfarin Reversal Consensus Group (2004) Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 181:492–497

    PubMed  Google Scholar 

  12. Dittus C, Ansell J (2013) The evolution of oral anticoagulant therapy. Prim Care 40:109–1034

    Article  PubMed  Google Scholar 

  13. Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European society of cardiology. Eur Heart J 28:230–268

    PubMed  Google Scholar 

  14. Salem DN, O’Gara PT, Madias C, Pauker SG, American College of Chest Physicians (2008) Valvular and structural heart disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133(6 Suppl):593S–629S

    Article  PubMed  Google Scholar 

  15. Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 52:e1–e142

    Article  PubMed  Google Scholar 

  16. Prince J, Hynes M, Labinaz M, Ruel M, Boodhwani M (2012) Mechanical valve thrombosis with dabigatran. J Am Coll Cardiol 60:1710–1711

    Article  Google Scholar 

  17. Stewart RA, Astell H, Young L, White HD (2012) Thrombosis on a mechanical aortic valve whilst anticoagulated with dabigatran. Heart Lung Circ 21:53–55

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Women’s Heart & Vascular Health, Texas Heart Institute at St. Luke’s Episcopal Hospital, 6624 Fannin, Suite 2780, Houston, TX, 77030, USA

    Stephanie Coulter & Karla Campos

Authors
  1. Stephanie Coulter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karla Campos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie Coulter.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Moving Image: Transesophageal echocardiogram shows immobilization of mechanical mitral hemi-disc with severe obstruction by a large thrombus (MPG 237 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coulter, S., Campos, K. Thrombosis on a mechanical mitral valve anticoagulated with dabigatran. J Thromb Thrombolysis 37, 84–86 (2014). https://doi.org/10.1007/s11239-013-0935-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-013-0935-7

Keywords

Search

Navigation